138 related articles for article (PubMed ID: 31466938)
1. Expression patterns of aquaporin 1 in vascular tumours.
Narváez-Moreno B; Sendín-Martín M; Jiménez-Thomas G; Sánchez-Silva R; Suárez-Luna N; Echevarría M; Bernabeu-Wittel J
Eur J Dermatol; 2019 Aug; 29(4):366-370. PubMed ID: 31466938
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
3. The genetics of vascular tumours: an update.
Torrence D; Antonescu CR
Histopathology; 2022 Jan; 80(1):19-32. PubMed ID: 34958509
[TBL] [Abstract][Full Text] [Related]
4. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients.
Dictor M; Rambech E; Way D; Witte M; Bendsöe N
Am J Pathol; 1996 Jun; 148(6):2009-16. PubMed ID: 8669485
[TBL] [Abstract][Full Text] [Related]
5. What is new in endothelial neoplasia?
Papke DJ; Hornick JL
Virchows Arch; 2020 Jan; 476(1):17-28. PubMed ID: 31463731
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms.
Requena L; Sangueza OP
J Am Acad Dermatol; 1997 Dec; 37(6):887-919; quiz 920-2. PubMed ID: 9418757
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
Kahn HJ; Bailey D; Marks A
Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy.
Arbiser JL; Weiss SW; Arbiser ZK; Bravo F; Govindajaran B; Caceres-Rios H; Cotsonis G; Recavarren S; Swerlick RA; Cohen C
J Am Acad Dermatol; 2001 Feb; 44(2):193-7. PubMed ID: 11174372
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Associated Protein Profiles in Kaposi Sarcoma and Mimicking Vascular Tumors, and Their Pathological Implications.
Lee KB; Lee KS; Lee HS
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31252633
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
11. Human herpesvirus 8 in Kaposi's sarcoma and Kaposi's sarcoma-mimicking vascular tumors.
Kang GH; Kwon GY; Kim CW
J Korean Med Sci; 1998 Feb; 13(1):54-9. PubMed ID: 9539320
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic growth factor expression in benign and malignant vascular tumours.
Young RJ; Fernando M; Hughes D; Brown NJ; Woll PJ
Exp Mol Pathol; 2014 Aug; 97(1):148-53. PubMed ID: 24984271
[TBL] [Abstract][Full Text] [Related]
13. Canine vascular neoplasia--a population-based clinicopathologic study of 439 tumours and tumour-like lesions in 420 dogs.
Gamlem H; Nordstoga K; Arnesen K
APMIS Suppl; 2008; (125):41-54. PubMed ID: 19385280
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic implication of Kaposi's sarcoma-associated herpesvirus with special reference to the distinction between spindle cell hemangioendothelioma and Kaposi's sarcoma.
Hisaoka M; Hashimoto H; Iwamasa T
Arch Pathol Lab Med; 1998 Jan; 122(1):72-6. PubMed ID: 9448021
[TBL] [Abstract][Full Text] [Related]
15. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors.
Xu H; Edwards JR; Espinosa O; Banerji S; Jackson DG; Athanasou NA
Hum Pathol; 2004 Jul; 35(7):857-61. PubMed ID: 15257549
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric DNA content in Kaposi's sarcoma by histologic stage. Comparison with angiosarcoma.
Dictor M; Fernö M; Baldetorp B
Anal Quant Cytol Histol; 1991 Jun; 13(3):201-8. PubMed ID: 1910421
[TBL] [Abstract][Full Text] [Related]
17. Imaging of vascular tumors with an emphasis on ISSVA classification.
Nozaki T; Matsusako M; Mimura H; Osuga K; Matsui M; Eto H; Ohtake N; Manabe A; Kusakawa I; Tsutsumi Y; Nosaka S; Kamo M; Saida Y
Jpn J Radiol; 2013 Dec; 31(12):775-85. PubMed ID: 24135879
[TBL] [Abstract][Full Text] [Related]
18. WT1 expression in angiogenic tumours of the skin.
Timár J; Mészáros L; Orosz Z; Albini A; Rásó E
Histopathology; 2005 Jul; 47(1):67-73. PubMed ID: 15982325
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms.
Requena L; Sangueza OP
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):143-75; quiz 176-8. PubMed ID: 9486670
[TBL] [Abstract][Full Text] [Related]
20. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
